Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

BMC Medicine, 2023
Integrated unbiased multiomics defines disease-independent placental clusters in common obstetrical syndromes

Barak O., Lovelace T., Piekos S. et al.

Olink Target 96ObstetricsPatient StratificationData ScienceTissue Lysate

European Journal of Epidemiology, 2023
Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults

Yao P., Iona A., Kartsonaki C. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Clinical and Experimental Dermatology, 2023
HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp

Zhang Y., Grice S., Wang N. et al.

Olink Target 96Dermatological DiseasesPathophysiologyCell Culture Supernatant

Neurobiology of Disease, 2023
Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach

Maple-Grødem J., Ushakova A., Pedersen K. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationCSF

Translational Neurodegeneration, 2023
Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease

Paslawski W., Khosousi S., Hertz E. et al.

Olink Target 96NeurologyPatient StratificationCSF

Clinical Immunology, 2023
Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children

Amodio D., Pascucci G., Cotugno N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Alimentary Pharmacology & Therapeutics, 2023
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease

Ungaro R., Hu L., Ji J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Journal of the American Heart Association, 2023
Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study

Xu Q., Sun L., Wang Y. et al.

Olink Target 96CVDPathophysiologyPlasma

Science Translational Medicine, 2023
A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Van Damme K., Hoste L., Declercq J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologySerum

Arthritis & Rheumatology, 2023
Elevation of IL‐17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders

Brodeur K., Liu M., Ibanez D. et al.

Olink Target 48Immunological & Inflammatory DiseasesCVDPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2023
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Anker J., Pal S., Kim-Schulze S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Journal of Cancer Research and Clinical Oncology, 2023
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study

Pham T., Nimptsch K., Papadimitriou N. et al.

Olink Target 96OncologyPathophysiologyPlasma

Antioxidants, 2023
Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents

Ullah A., Stankevic E., Holm L. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Journal of Cerebral Blood Flow & Metabolism, 2023
A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease

Overmars L., Kuipers S., van Es B. et al.

Olink Target 96CVDPathophysiologyPlasma

iScience, 2023
Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19

Shivram H., Hackney J., Rosenberger C. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologySerumBlood

eClinicalMedicine, 2023
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study

Zinzani P., Trněný M., Ribrag V. et al.

Olink Target 96OncologyPathophysiologyPlasma

Nature Genetics, 2023
Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis

Zhou S., Sosina O., Bovijn J. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Research and Practice in Thrombosis and Haemostasis, 2023
Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach

Liu Z., McCutcheon F., Ho H. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

Brain, Behavior, and Immunity, 2023
Machine learning models of plasma proteomic data predict mood in chronic stroke and tie it to aberrant peripheral immune responses

Bidoki N., Zera K., Nassar H. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Nature Aging, 2023
Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging

Rosoff D., Mavromatis L., Bell A. et al.

Olink Target 96AgingPathophysiologyPlasma

3478 publications